City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...

This roundup highlights a common drug that can help treat multiple myeloma, a paper analyzing the benefit of a colorectal surgery follow-up test ...

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

Multiple myeloma is a blood cancer that affects your ... These can include: liver damage new cases of acute myeloid leukemia (AML) neuropathy (numbness or weakness in your nerves) blood clots ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR ...

New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan. 14 ... Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive ...

Reports FY24 revenue $107.9M, consensus $121.7M. “2024 was a transformational year for Arcellx (ACLX) as our ASH data presentations for ...